Naloxone and Buprenorphine for Adolescent Opioid Overdose and Use Disorder This narrative review summarizes literature on opioid use, overdose, and misuse among adolescents as well as the use of naloxone and buprenorphine in adolescent opioid treatment.

Regulatory changes have expanded #Naloxone and #Buprenorphine access, but adolescents remain under-treated for opioid overdose and use disorder despite persistently high overdose fatalities. ja.ma/4rT79Ck

Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum This randomized clinical trial evaluates whether weekly extended-release buprenorphine has noninferior effectiveness and safety outcomes compared with sublingual buprenorphine among pregnant adults wi...

Pacientes con trastorno por uso de opioides pueden recibir buprenorfina de liberación extendida una vez por semana durante el embarazo #pregnancy #OUD #buprenorphine jamanetwork.com/journals/jam...

Today's the day! Join us this afternoon ET:

#HarmReduction #HarmReductionSavesLives #Treatment #OverdoseEpidemic #EndOverdose #HarmReductionIsHealthCare #HarmReductionIsLove #PreventOverdose #PublicHealth #OverdosePrevention #BodilyAutonomy #Methadone #Buprenorphine #MOUD #DrugTreatment

This, #Buprenorphine, is what the vet gave my cat for pain. She did not sleep or blink for 3 days, couldn't meow, could barely walk, jumped at every sound. She's still not herself. I hope she fully comes back. DON'T let vets give this to your cat. Plz repost to warn others.

youtu.be/Ve0d02Kop5Y?...

An editorial from JAMA, published online February 11, 2026, titled "Buprenorphine in the ED—Balancing Access, Safety, and Autonomy" by Jessica Moe, Andrew Kestler, and Isabelle Miles, discusses emergency department visits for individuals with opioid use disorder.

💬 Editorial: ED-initiated extended-release injectable and sublingual #Buprenorphine show similar short-term engagement and low precipitated withdrawal rates, but further data on safety and adherence are needed.

ja.ma/4beZBVk

Infographic showing study results: injectable vs. sublingual buprenorphine for opioid disorder. Population: 1348 male, 646 female, adults in EDs; 29 US locations. Intervention: 991 got extended-release, 1003 got sublingual. Findings: no significant difference in treatment engagement.

Among adults presenting to the emergency department with untreated #opioid use disorder, ED-initiated 7-day extended-release injectable #buprenorphine and sublingual buprenorphine resulted in similar rates of treatment engagement at 7 days.

ja.ma/4bqdbnC

#PsychSciSky #DrugSky #PharmSky #MedSky #AddictionSci #NeuroSky #EpiSky #StatsSky #HealthPolicy @tandfresearch.bsky.social #methadone #buprenorphine #HarmReduction #HealthEquity #PublicHealth

Outpatient initiation of direct-to-inject buprenorphine Fentanyl-involved overdose deaths have surged, yet buprenorphine remains underutilized for opioid use disorder (OUD) treatment, partly due to the risk…

#Research Readings: Outpatient initiation of direct-to-inject #buprenorphine

www.sciencedirect.com/science/article/pii/S037...

#CROI2026 #idsky #HIVsky Poster: An Ultra-Long-Acting #Buprenorphine Prodrug (AM-510) for Opioid Use Disorder: by Ashrafi Sultana.
A single SC dose of AM 510 sustains plasma concentrations of BUP above target Ctrough of clinically efficacious oral SUBOXONE for over 5 months.

Mark your calendar and join us for the free March Foundational Fridays session, focused on #Treatment medications!

#HarmReduction #HarmReductionSavesLives #OverdoseEpidemic #EndOverdose #PreventOverdose #PublicHealth #OverdosePrevention #BodilyAutonomy #Methadone #Buprenorphine

New Study Shows Low-Dose Ketamine Can Aid Fentanyl Users Transition to Buprenorphine Therapy Recent findings indicate that low doses of ketamine can significantly ease fentanyl withdrawal symptoms, paving the way for safer transitions to buprenorphine treatment.

New Study Shows Low-Dose Ketamine Can Aid Fentanyl Users Transition to Buprenorphine Therapy #United_States #Mobile #Ketamine #fentanyl #Buprenorphine

Two graphs depict buprenorphine prescriptions vs. time since ACA expansion. Top: Recent Medicaid expansions show a slight increase post-expansion. Bottom: Early Medicaid expansions show a more noticeable increase after expansion.

Recent #Medicaid expansions (2019 or later) were associated with a significant increase in all-payer #Buprenorphine dispensing for #OpioidUseDisorder, particularly in high-need states, compared with earlier expansions.

ja.ma/40hbDXN

Over blue gradient, conversation bubbles in white and black with patterns at top right read, “FOUNDATIONAL FRIDAYS.” Below this, between black box outline, bold, all caps black copy reads, “THE BASICS OF MOUD". Some words are highlighted in yellow. Smaller black font at bottom middle reads, "March 27" and “12 p.m. — 2 p.m. ET”. Black and white NHRC 30th anniversary logo at bottom left.

🧵Each person knows their own needs best, & for some, that can include drug #Treatment &/or taking medications for #Opioid use disorder (MOUD). Learn more about these options & #MOUD including #Buprenorphine & #Methadone during our March Foundational Fridays...

bit.ly/FoundationalFridaysMOUD2026

ATTC/CTN Webinar Series: Problems Initiating Buprenorphine Treatment Among Patients Using Fentanyl. February 25, 2026, 11am-12:30pm PT. 1.5 CME/CE Available. Sponsored by the Northwest & Pacific SW ATTCs and the NIDA CTN Western States Node

What kinds of challenges are clinicians experiencing when starting patients who use #fentanyl on #buprenorphine and how are they overcoming those challenges? Find out in this February 25 webinar from the Northwest ATTC at ADAI!

Register: washington.zoom.us/webinar/regi...

💬 Editorial: ED-initiated extended-release injectable and sublingual #Buprenorphine show similar short-term engagement and low precipitated withdrawal rates, but further data on safety and adherence are needed.

bit.ly/4twkBhi

JAMA Pediatrics Review: "Naloxone and Buprenorphine Treatment for Adolescent Opioid Overdose and Opioid Use Disorder: A Review" by Alexis Ball, et al. Discusses opioid crisis impact on adolescents, naloxone, and buprenorphine use.

Regulatory changes have expanded #Naloxone and #Buprenorphine access, but adolescents remain under-treated for opioid overdose and use disorder despite persistently high overdose fatalities.

bit.ly/4kmhvZ6

This was a great session from the Northwest ATTC, with lots of info from the clients they've worked with on their experiences with long-acting injectable #buprenorphine for opioid use disorder (especially #fentanyl).

If you missed it, check out the recording here: attcnetwork.org/products_and...

Buprenorphine Can Be Initiated via an Injectable-only Three-day Overlapping Protocol | Alcohol, Other Drugs, and Health: Current Evidence

A new AOD Health review highlights a three‑day, injectable‑only #Buprenorphine induction option for individuals using fentanyl who want to avoid sublingual dosing. Early results show strong short‑term retention in low‑threshold outpatient settings.

🔗 Read more: buff.ly/60Sbvur

#AddictionMedicine

Northwest ATTC Webinar: Outreach-Based Long-Acting Injectable Buprenorphine (Jan. 21, 2026, 12-1pm PT) - Addictions, Drug & Alcohol Institute Jeremy Hoog & Carson Bell of DESC Join presenters Jeremy Hoog, RN, BSN, MA, and Carson Bell, MPH of the Downtown Emergency Service Center (DESC) in Seattle, WA for the first Northwest ATTC webinar of ...

NEXT WEDNESDAY! Learn how long-acting #buprenorphine can help close treatment gaps for people with OUD in outreach settings, including permanent supportive housing sites, and get tips on how to identify and advocate for creative client-centered engagement strategies!

adai.uw.edu/northwest-at...

Downward Dog for Opioid Withdrawal? Early trial shows that yoga, alongside standard care, accelerated opioid withdrawal recovery

"Opioid withdrawal is notoriously difficult to treat." -- Kevin Hill, MD, MHS, of @harvardmed.bsky.social, discussing a study that found adding #yoga to standard #buprenorphine therapy hastened opioid withdrawal recovery.
www.medpagetoday.com/psychiatry/o...

MultiSearch Tag Explorer MultiSearch Tag Explorer - Explore tags and search results by aéPiot

#ANDRÉS #BOTTIGLIERI
allgraph.ro/advanced-sea...
#BUPRENORPHINE #NALOXONE
headlines-world.com/advanced-sea...
#VICTOR #DEGRAILLY
multi-search-tag-explorer.headlines-world.com/advanced-sea...
aepiot.com

Outreach-based long-acting injectable buprenorphine: A viable pathway to closing OUD treatment gaps. January 21, 2026, 12-1pm PT. Certificate of attendance available. Sponsored by the Northwest ATTC.

Join the Northwest ATTC on Jan. 21 for this free webinar, in which two speakers from Seattle's Downtown Emergency Service Center will talk about how long-acting injectable #buprenorphine offered in outreach settings is helping break down barriers to care. Register: washington.zoom.us/webinar/regi...

New Research Unveils Promising Results of Extended-Release Buprenorphine in Fighting Opioid Use Disorder A recent clinical trial reveals that both doses of extended-release buprenorphine significantly reduce opioid use among high-risk individuals, showcasing the need for innovative treatment strategies.

New Research Unveils Promising Results of Extended-Release Buprenorphine in Fighting Opioid Use Disorder #USA #Richmond #opioid_use_disorder #Buprenorphine #INDV

A 3-day #buprenorphine microinduction safely transitioned hospitalized patients with #OUD and pain—zero withdrawal cases, high success rate (87.8%). A promising way to improve comfort, safety, and retention. www.tandfonline.com/doi/full/10....
#Opioids #AddictionTreatment #HarmReduction

Exploring the effects of cannabidiol on pain sensitivity using quantitative sensory testing among individuals receiving methadone or buprenorphine for opioid use disorder: an open-label, proof-of-conc... While medications for opioid use disorder (MOUD) effectively treat opioid use disorder (OUD), concurrent pain management remains challenging. Cannabid…

Can #cannabidiol (CBD) help #pain in people with #OpioidUseDisorder? Our proof-concept study suggests CBD may modulate pain differently depending on whether people are on #methadone or #buprenorphine, with promising signals at lower doses and good tolerability.

shorturl.at/jlB7V

Four graphs show buprenorphine prescriptions in North & South Carolina from June 2023 to Dec 2024. Graphs show prescriptions regardless of payer, and paid by Medicaid, private insurance, or cash, noting percentages of patients.

North Carolina’s Dec 1, 2023 #Medicaid expansion was associated with a modest slowing of the decline in #buprenorphine dispensing after Medicaid unwinding, supporting Medicaid expansion’s help in preserving access to opioid use disorder treatment. #OUD ja.ma/48KmjCe

CP3's Dr. Jenny Lo-Ciganic was part of a team that examined associations between trajectories of #buprenorphine use & time to adverse outcomes among youth. Bottom line: Medication adherence may prevent overdose, ED use, and hospitalization.

Read more: publications.aap.org/pediatrics/a...

APhA's Legislative Triumph Expands Pharmacists' Role in Buprenorphine Prescribing and Opioid Treatment The American Pharmacists Association celebrates a legislative success allowing pharmacists to prescribe buprenorphine following specialized training, crucial in battling opioid crisis.

APhA's Legislative Triumph Expands Pharmacists' Role in Buprenorphine Prescribing and Opioid Treatment #United_States #Washington #APhA #Opioid_Treatment #Buprenorphine

#Research Reading: #Buprenorphine, #Pain, and #Opioid Use in Patients Taking High-Dose Long-Term Opioids

jamanetwork.com/journals/jamainternalmed...

Trends in Methadone and Buprenorphine Use by Indication Among Medicaid Enrollees, 1999-2020. The graph plots prevalence of use per 1000 Medicaid enrollees, showing Methadone for pain, Methadone for OUD, and Buprenorphine for OUD.

#Methadone and #buprenorphine use for #OUD among Medicaid enrollees increased from 1999 to 2020, contrary to prior reports of declining methadone use in this population. ja.ma/47V6aL2